Shopping Cart 0
Cart Subtotal
USD 0

Thermo Fisher Scientific Inc (TMO) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Thermo Fisher Scientific Inc (Thermo Fisher) is a provider of equipment, analytical instruments, reagents and consumables, software and services to tackle complex analytical challenges in research, diagnostics and clinical laboratories. It offers solutions for cellular analysis and biology, flow cytometry and synthetic biology. The company's product portfolio includes technologies for mass spectrometry, electron microscopy, genetic sequencing, protein and molecular biology research. The company serves pharmaceutical and biotech companies, academic and research institutions, clinical diagnostic labs, and government agencies; and environmental, industrial quality and process control sectors. It sells its products and services through direct sales force, e-commerce and third-party distributors in the Americas, Asia-Pacific and Europe. Thermo Fisher is headquartered in Waltham, Massachusetts, the US.

Thermo Fisher Scientific Inc (TMO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 9

List of Figures 12

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 13

Thermo Fisher Scientific Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 14

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 15

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 16

Thermo Fisher Scientific Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 17

Thermo Fisher Scientific Inc, Medical Equipment, Deal Details 24

Asset Purchase 24

Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from Becton, Dickinson and Company 24

Visualization Sciences Completes Acquisition Of Amira 3D Visualization And Analysis Software From Visage Imaging For USD 15 Million 25

Thermo Fisher Scientific Acquires Rights To Pre-eclampsia Biomarker From Nephromics 26

Venture Financing 27

Linkage Biosciences Raises USD 2 Million In Series C Financing 27

IntegenX Raises USD 49 Million In Venture Financing 28

Linkage Biosciences Raises USD 1.5 Million In Venture Financing 29

KonTEM Raises Funds Through Venture Financing 30

Private Equity 31

GTCR Completes Acquisition of Cole-Parmer from Thermo Fisher for USD480 Million 31

Partnerships 32

Thermo Fisher Enters into Licensing Agreement with Siemens Healthineers 32

One Lambda Enters into Licensing Agreement with Transcriptome Sciences 33

Singulex Enters into Licensing agreement with Thermo Fisher Scientific 34

Thermo Fisher Scientific Enters into Licensing Agreement with Probiogen for GlymaxX Technology 35

Affymetrix Enters into Licensing Agreement with Peptide Groove 36

diaDexus Enters Into Licensing Agreement With Thermo Fisher Scientific 37

Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 38

Thermo Fisher Scientific Extends Licensing Agreement With Roche For Procalcitonin Test 39

Medicyte Enters Into Licensing Agreement With Life Technologies For Next Generation Upcyte Cells 40

Life Technologies Enters Into Licensing And Research Agreement With Harvard For Stem Cell Assay 41

Affymetrix Enters Into Licensing Agreement With DNA Link To Develop Forensic And Other Diagnostic Tests 42

Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 43

Vela Diagnostics Enters Into Licensing Agreement With Life Technologies 44

Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology 45

Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology 46

Thermo Fisher Scientific Extends Licensing Agreement With Wako Pure Chemical Industries 47

PharmaFluidics Enters into Partnership Agreement with Thermo Fisher 48

Thermo Fisher and Evosep Enter into Partnership 49

Spectrum Pharma Enters into Agreement with Thermo Fisher Scientific 50

Thermo Fisher and Leica Microsystems Enter into Partnership 51

Ortho Clinical Diagnostics Enters into Distribution and Co-Promotion Agreement with Thermo Fisher Scientific 52

BioDiscovery Enters into Agreement with Thermo Fisher Scientific 53

Thermo Fisher Scientific Enters into Agreement with Blueprint Medicines 54

Genomics England, Inivata and Thermo Fisher Enter into Agreement 55

Seegene Enters into Agreement with Thermo Fisher Scientific 56

Thermo Fisher Scientific Enters into Agreement with Agios Pharma 57

Thermo Fisher Scientific Enters into Agreement with Institute of Medical Genetics and Pathology at University Hospital 58

Asuragen Enters into Agreement with Thermo Fisher Scientific 59

Invivoscribe Enters into Agreement with Thermo Fisher Scientific 60

Biocartis Group Enters into Distribution Agreement with Thermo Fisher Scientific 61

Thermo Fisher Scientific Enters into Agreement with Hamilton Storage Technologies 62

Thermo Fisher Scientific Enters into Co-Development Agreement with HEALTH BioMed 63

Thermo Fisher Scientific Enters into Co-Development Agreement with Cytonome 64

Strata Oncology Enters into Agreement with Thermo Fisher Scientific 65

Thermo Fisher Scientific Partners with University of Birmingham 66

HTG Molecular Diagnostics Enters into Agreement with Thermo Fisher Scientific 67

HTG Molecular Diagnostics Enters into Co-Development Agreement with Life Technologies 68

Thermo Fisher Scientific Enters into Co-Development Agreement with Children's Hospital Los Angeles 69

Invivoscribe Enters into Co-Development Agreement with Thermo Fisher Scientific 70

Affymetrix Enters into Agreement with Reveal Biosciences 71

Thermo Fisher Scientific Enters into Agreement with Novartis and Pfizer 72

Agilent Technologies Enters into Agreement with Thermo Fisher Scientific 73

XRGenomics Enters into Research Agreement with Affymetrix 74

Affymetrix Enters into Distribution Agreement with Luminex 75

Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 76

Cytox Enters into Joint Development Partnership with Affymetrix 77

Atossa Genetics Enters into Distribution Agreement with Thermo Fisher 78

Thermo Fisher Scientific Enters into Distribution Agreement with Cynvenio Biosystems 79

Thermo Fisher Scientific Enters into Co-Development Agreement with Samsung Electronics 80

Ingen Expands Distribution Agreement with One Lambda 81

Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 82

Lucigen Enters into Agreement with Thermo Fisher Scientific 83

Nuclea Biotech Enters into Co-Development Agreement with Thermo Fisher Scientific 84

Thermo Fisher Scientific Enters into Co-Development Agreement with Agricultural Research Service and Pennsylvania State University 85

Affymetrix Enters Into Integration Agreement With CollabRx 86

Copan Diagnostics Enters Into Distribution Agreement With Thermo Fisher For WASP 87

OraSure Technologies Enters Into Co-Development Agreement With Thermo Fisher 88

Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit 89

Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 90

Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 91

Life Technologies Enters Into Agreement With RainTree For Molecular Tumor Testing 92

Rheonix Enters Into Co-Development Agreement With Life Technologies For Molecular Testing Platform 93

Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics 94

Thermo Fisher Scientific And NLIPCC Enter Into R&D Agreement For Personalized Cancer Treatment 95

Atossa Genetics Enters Into Distribution Agreement With Fisher Healthcare For Breast Health Devices 96

Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 97

Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools 98

Life Tech Enters Into Distribution Agreement With LGC Forensics For ParaDNA 99

Thermo Fisher Scientific Enters Into Research Agreement With University of Birmingham 100

Life Technologies And IMEGEN Enter Into Agreement To Develop DNA Test 101

Response Biomedical Enters Into Distribution Agreement With Fisher HealthCare 102

BioDesign Institute Enters Into Co-Development Agreement With Life Technologies 103

Affymetrix Enters Into Agreement With Hamilton Robotics To Develop Cytogenetics Assay 104

Boston Children's Hospital Enters Into Joint Venture With Life Technologies To Form Claritas Genomics 105

Biocept Enters into Partnership with Life Technologies 106

Thermo Fisher Enters Into Co-Development Agreement With Immundiagnostik 107

Ingenuity Systems Enters Into Co-Development Agreement With Life Technologies For Diagnostic Solutions 108

CollabRx Enters Into Co-Development Agreement With Life Technologies 109

Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 110

Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 111

Life Technologies Enters Into Agreement With Bristol-Myers Squibb For Companion Diagnostics Development 112

Affymetrix Enters Into Co-Development Agreement With Pathgen Dx 113

Life Technologies and Southern African Treatment and Resistance Network Partner In Sequencing-Based Surveillance of Drug Resistance 114

Gen-Probe Enters Into Co-Marketing Agreement With Life Technologies 115

One Lambda Enters Into Co-Marketing Agreement With CellTrend 116

Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests 117

Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 118

Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 119

Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology 120

Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products 121

Iris International Enters Into Distribution Agreement With Fisher HealthCare 122

IRIS Sample Processing Enters Into Distribution Agreement With Fisher HealthCare 123

Thermo Fisher Scientific Enters Into Distribution Agreement With BellBrook Labs 124

Aushon BiosyStems Enters Into Distribution Agreement With Fisher Scientific 125

Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis 126

Life Technologies Enters Into Joint Venture Agreement With DaAn Gene 127

Eppendorf Enters into Licensing Agreement with Life Tech and Alpha Labs 128

Life Technologies Enters Into Licensing Agreement With Novartis 129

Thermo Fisher Scientific Enter Into Licensing Agreement With Protein Metric For Proteomics Software 130

Equity Offering 131

Thermo Fisher Scientific Prices Public Offering of Shares for USD1.5 Billion 131

Affymetrix to Raise USD50 Million in Private Placement of Shares 133

Thermo Fisher Scientific Announces Private Placement Of Common Stock For USD 500 Million 134

Thermo Fisher Completes Public Offering Of Shares For USD 2.53 Billion 135

Patheon Completes Rights Offering Of Shares For USD 30 Million 137

Affymetrix Files Registration Statement For Public Offering Of Securities For USD 200 Million 138

Debt Offering 139

Thermo Fisher Scientific Prices Public Offering of Notes Due 2020 for USD694 Million 139

Thermo Fisher Scientific Raises USD750 Million in Public Offering of 3.2% Notes Due 2027 140

Thermo Fisher Scientific Raises USD750 Million in Public Offering of 4.1% Notes Due 2047 142

Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.4% Notes Due 2026 144

Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 2.875% Notes Due 2037 146

Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.95% Notes Due 2029 148

Thermo Fisher Scientific Raises USD573.3 Million in Public Offering of Floating Rate Notes Due 2019 150

Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million 152

Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes 154

Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028 156

Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028 158

Thermo Fisher Scientific Raises USD1 Billion in Public Offering of 3% Notes Due 2023 160

Thermo Fisher Scientific Raises USD350 Million in Public Offering of 3.65% Notes Due 2025 161

Thermo Fisher Scientific Raises USD450 Million in Public Offering of 2.150% Notes Due 2018 162

Thermo Fisher Scientific Raises USD457 Million in Public Offering of 1.5% Notes Due 2020 163

Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022 165

Thermo Fisher Scientific Raises USD801 Million in Public Offering of 2% Notes Due 2025 167

Thermo Fisher Scientific Raises USD800 Million in Public Offering of 3.3% Notes Due 2022 169

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2044 For USD 400 Million 171

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2024 For USD 1 Billion 173

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2019 For USD 900 Million 175

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2017 For USD 900 Million 177

Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2018 For USD 500 Million 179

Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2023 For USD 800 Million 181

Affymetrix Completes Public Offering Of Notes Due 2019 For USD 105 Million 183

Acquisition 185

Thermo Fisher Scientific Acquires IntegenX 185

One Lambda Acquires Linkage Biosciences 186

Thermo Fisher Scientific Acquires Finesse Solutions 187

Thermo Fisher Scientific Acquires FEI for USD4.2 Billion 188

Thermo Fisher Scientific May Acquire Illumina for USD30 Billion 190

Thermo Fisher Scientific Acquires Affymetrix for up to USD1.3 Billion 191

Thermo Fisher Scientific Acquires INEL 193

Thermo Fisher Scientific Acquires Advanced Scientifics for USD289 Million 194

FEI Company Acquires KonTEM, Developer of Innovative Phase Contrast System for TEM 195

EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For USD 4 Million 196

Thermo Fisher Scientific Completes Acquisition Of Life Technologies For USD 13.6 Billion 197

FEI Company To Acquire nanoTechnology Systems 200

Life Technologies Acquires KDR Biotech, Distributor Of Reagents 201

Thermo Fisher Scientific Acquires picoSpin, Maker Of Miniature Nuclear Magnetic Resonance Spectrometer 202

Life Technologies Acquires Advanced Microscopy, Maker Of Microscopes 203

Thermo Fisher Scientific Completes Acquisition Of One Lambda, Transplant Diagnostics Company, For USD 925 Million 204

FEI Acquires Visualization Sciences, 3D Visualization Software Company, For USD 55 Million 206

Life Technologies Acquires Pinpoint Genomics, Molecular Diagnostics Company 207

Life Technologies Acquires Navigenics 208

Affymetrix Completes Acquisition Of eBioscience For USD 315 Million 209

IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences 211

Life Technologies Acquires Immuno-Magnetic Diagnostics Company, Matrix MicroScience 212

Thermo Fisher Scientific Inc - Key Competitors 213

Thermo Fisher Scientific Inc - Key Employees 214

Thermo Fisher Scientific Inc - Locations And Subsidiaries 216

Head Office 216

Other Locations & Subsidiaries 216

Joint Venture 220

Recent Developments 221

Strategy And Business Planning 221

Oct 02, 2018: Seoul St Mary s Hospital and Singapore General Hospital join Thermo Fisher Scientific s Next-Generation Sequencing Center of Excellence Program 221

Sep 20, 2018: Thermo Fisher scientific to launch global customer solution centers 222

Jun 04, 2018: Thermo Fisher Scientific Opens U.S. Precision Medicine Science Center 223

Mar 16, 2018: Thermo Fisher Scientific Announces Plans To Build State-Of-The-Art Pharma Services Facility In Rheinfelden 224

Dec 29, 2017: Thermo Fisher Scientific Completes Acquisition of Phenom-World 225

Financial Announcements 226

Jul 25, 2018: Thermo Fisher Scientific reports second quarter 2018 results 226

Apr 25, 2018: Thermo Fisher Scientific Reports First Quarter 2018 Results 228

Jan 31, 2018: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2017 Results 230

Oct 25, 2017: Thermo Fisher Scientific Reports Third Quarter 2017 Results 232

Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 235

Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific 237

Apr 26, 2017: Thermo Fisher Scientific Reports First Quarter 2017 Results 238

Jan 31, 2017: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results 240

Corporate Communications 242

Jul 09, 2018: Thermo Fisher Offers to Donate DNA Analyzers to Support US-Mexico Border Family Reunions 242

Jun 24, 2018: Thermo Fisher Scientific Donates Rapid DNA Analysis Technology to Help Reunite Families Recently Separated at Border 243

Jan 22, 2018: Secured loan facility agreement with Thermo Fisher 244

Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific 245

Mar 01, 2017: Thermo Fisher Scientific Elects New Director to Board 246

Legal and Regulatory 247

Mar 27, 2018: New Salmonella Multiplex PCR Solution for Simultaneous Detection of Three Salmonella Targets in One Rapid Test is Now Certified by AFNOR 247

Jan 23, 2017: ISO 17025 Accreditation for Microbiology Manufacturing Site Offers Increased Confidence to Microbiology Testing Laboratories 248

Product News 249

Sep 24, 2018: New Single Quadrupole Mass Spectrometry Technology Designed for Chromatographers Performing LC-MS Routine Analysis 249

Aug 06, 2018: Thermo Fisher Scientific Showcases New Electron Microscopy and Microanalysis Solutions at M&M 2018 250

Jul 31, 2018: New triple quadrupole mass spectrometer offers robust and fast analysis with LC-MS/MS for clinical research laboratories 252

Jul 02, 2018: Latin American Structural Biologists Gain Access to Cryo-EM Capabilities 253

Jun 28, 2018: Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Assay Portfolio 254

Jun 25, 2018: New Twin-screw Granulator Helps Maximize Throughput in Continuous Drug Manufacturing 255

Jun 18, 2018: Thermo Fisher Scientific Launches Ion AmpliSeq HD Technology 256

Jun 04, 2018: New Ultra-High Mass Range Mass Spectrometer Provides Solution for Analysis of Proteins and Protein Complexes 257

Jun 04, 2018: Thermo Fisher Scientific showcases newest products at ASMS 2018 258

Apr 26, 2018: Thermo Scientific Explorer 4 Additive Scanning Electron Microscope Delivers First Dedicated Solution for 3D Printing Process Control 260

Apr 16, 2018: Thermo Fisher Scientific Launches Oncomine Childhood Cancer Research Assay and Establishes International Childhood Oncology Network 261

Apr 12, 2018: Thermo Fisher Scientific to Showcase Clinical Research Advances in Immuno-Oncology at AACR 262

Apr 10, 2018: Thermo Fisher launches five new products at Analytica 2018 263

Apr 10, 2018: Thermo Fisher Scientific Highlights Digital Science Innovations at Analytica 2018 264

Feb 27, 2018: Thermo Fisher Scientific Innovations Offer Greater Connectivity and Ease of Use 266

Feb 05, 2018: Thermo Fisher Scientific Launches Axiom Microbiome Array for Research 267

Jan 08, 2018: Thermo Fisher Scientific Expands Oncomine Portfolio for Liquid Biopsy and Immuno-oncology Clinical Research 268

Jan 08, 2018: Thermo Fisher Scientific Introduces Ion GeneStudio S5 Series, A Line of Highly Versatile Next Generation Sequencers 270

Dec 07, 2017: New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes 271

Nov 27, 2017: Expanded Genome Editing Tool Kit Supports Every Step in Researchers' Workflow 272

Nov 04, 2017: Thermo Fisher Scientific Showcases Large-scale Precision Medicine Research Studies in Genotyping 273

Oct 17, 2017: Thermo Fisher Scientific Customers to Showcase Innovations in Precision Genomics Research for Inherited Disease and Reproductive Health at ASHG 274

Sep 26, 2017: Thermo Fisher Scientific Continues to Expand Plasmid DNA Purification Portfolio of Low-Endotoxin Plasmid DNA Isolation Kits 275

Sep 05, 2017: New Study Confirms High Technical Comparability of Different BRAHMS PCT Assays at all Clinical Cut-offs for Various Clinical Settings 276

Aug 31, 2017: Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research Across Europe 277

Aug 07, 2017: Thermo Fisher Scientific Showcases Innovations in Electron Microscopy and Spectroscopy at M&M 2017 278

Jul 31, 2017: Thermo Fisher Scientific Advances Innovation for the Clinic at AACC 2017 279

Jun 29, 2017: New FDA-Cleared Microbroth Dilution Susceptibility Testing Plate Expands Patient Treatment Options for Gram Negative Infections 280

Jun 05, 2017: Thermo Fisher Scientific and BIOCRATES Life Sciences Launch Industry's First Kit for Comprehensive Metabolome Analysis 281

Jun 02, 2017: Newly Redesigned Panels Align with Most Recent Published Evidence to Drive Cancer Research 282

May 24, 2017: New On-Demand Targeted Next-Generation Sequencing Panels for Inherited Disease Research Deliver User Customization Without High Upfront Cost 283

May 22, 2017: Thermo Fisher Scientific Introduces Latest in Capillary Electrophoresis Technology with new Applied Biosystems SeqStudio Genetic Analyzer 284

Mar 21, 2017: New Comprehensive Carrier Screening Research Assay Features Richest Pan-Ethnic Panel for Detection of Multiple Genetic Variations in Inherited Disease 285

Mar 20, 2017: Thermo Fisher Scientific Showcases Newest Bioprocessing Technologies at INTERPHEX 286

Other Significant Developments 287

Oct 02, 2018: Seoul St. Mary''s Hospital and Singapore General Hospital join Thermo Fisher Scientific''s next-generation sequencing Center of Excellence Program 287

Jul 10, 2018: Thermo Fisher Scientific to publish antibody data 288

May 18, 2018: Bard1 Enters agreement to Develop a Research-Use-Only Auto antibody Test System Using Procartaplex Technology 289

Mar 28, 2018: Biocept and Thermo Fisher Scientific Enter into Technology and Commercial Collaboration 290

Mar 21, 2018: Thermo Fisher says UK job cuts not Brexit-related 291

Feb 21, 2018: Millions of U.S. Allergy Sufferers Now Have Access to Advanced Diagnostic Tests 292

Feb 13, 2018: OpGen Strengthens Supplier Relationship to Use Industry-Leading Real-Time PCR Technology for New Acuitas Tests 293

Jan 31, 2018: Thermo Fisher Scientific Uses Tax Reform Benefit to Make Additional Investments in Colleagues, Customers and Communities 294

Jan 08, 2018: Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology 295

Sep 07, 2017: Institute of Pathology Heidelberg Joins Thermo Fisher Scientific Center of Excellence Program to Drive Oncology Companion Diagnostic Development in Europe 296

Jun 12, 2017: Allergen Sensitization Testing Breakthrough Marks 50th Anniversary 297

May 04, 2017: New Licensing Program Facilitates Adoption of Tandem Mass Tag Technology 298

Appendix 299

Methodology 299

About GlobalData 299

Contact Us 299

Disclaimer 299


List Of Figure

List of Figures

Thermo Fisher Scientific Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 13

Thermo Fisher Scientific Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 14

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 15

Thermo Fisher Scientific Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 16


List Of Table

List of Tables

Thermo Fisher Scientific Inc, Medical Equipment, Key Facts, 2017 2

Thermo Fisher Scientific Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 13

Thermo Fisher Scientific Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 14

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 15

Thermo Fisher Scientific Inc, Deals By Market, 2012 to YTD 2018 16

Thermo Fisher Scientific Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 17

Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from Becton, Dickinson and Company 24

Visualization Sciences Completes Acquisition Of Amira 3D Visualization And Analysis Software From Visage Imaging For USD 15 Million 25

Thermo Fisher Scientific Acquires Rights To Pre-eclampsia Biomarker From Nephromics 26

Linkage Biosciences Raises USD 2 Million In Series C Financing 27

IntegenX Raises USD 49 Million In Venture Financing 28

Linkage Biosciences Raises USD 1.5 Million In Venture Financing 29

KonTEM Raises Funds Through Venture Financing 30

GTCR Completes Acquisition of Cole-Parmer from Thermo Fisher for USD480 Million 31

Thermo Fisher Enters into Licensing Agreement with Siemens Healthineers 32

One Lambda Enters into Licensing Agreement with Transcriptome Sciences 33

Singulex Enters into Licensing agreement with Thermo Fisher Scientific 34

Thermo Fisher Scientific Enters into Licensing Agreement with Probiogen for GlymaxX Technology 35

Affymetrix Enters into Licensing Agreement with Peptide Groove 36

diaDexus Enters Into Licensing Agreement With Thermo Fisher Scientific 37

Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 38

Thermo Fisher Scientific Extends Licensing Agreement With Roche For Procalcitonin Test 39

Medicyte Enters Into Licensing Agreement With Life Technologies For Next Generation Upcyte Cells 40

Life Technologies Enters Into Licensing And Research Agreement With Harvard For Stem Cell Assay 41

Affymetrix Enters Into Licensing Agreement With DNA Link To Develop Forensic And Other Diagnostic Tests 42

Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 43

Vela Diagnostics Enters Into Licensing Agreement With Life Technologies 44

Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology 45

Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology 46

Thermo Fisher Scientific Extends Licensing Agreement With Wako Pure Chemical Industries 47

PharmaFluidics Enters into Partnership Agreement with Thermo Fisher 48

Thermo Fisher and Evosep Enter into Partnership 49

Spectrum Pharma Enters into Agreement with Thermo Fisher Scientific 50

Thermo Fisher and Leica Microsystems Enter into Partnership 51

Ortho Clinical Diagnostics Enters into Distribution and Co-Promotion Agreement with Thermo Fisher Scientific 52

BioDiscovery Enters into Agreement with Thermo Fisher Scientific 53

Thermo Fisher Scientific Enters into Agreement with Blueprint Medicines 54

Genomics England, Inivata and Thermo Fisher Enter into Agreement 55

Seegene Enters into Agreement with Thermo Fisher Scientific 56

Thermo Fisher Scientific Enters into Agreement with Agios Pharma 57

Thermo Fisher Scientific Enters into Agreement with Institute of Medical Genetics and Pathology at University Hospital 58

Asuragen Enters into Agreement with Thermo Fisher Scientific 59

Invivoscribe Enters into Agreement with Thermo Fisher Scientific 60

Biocartis Group Enters into Distribution Agreement with Thermo Fisher Scientific 61

Thermo Fisher Scientific Enters into Agreement with Hamilton Storage Technologies 62

Thermo Fisher Scientific Enters into Co-Development Agreement with HEALTH BioMed 63

Thermo Fisher Scientific Enters into Co-Development Agreement with Cytonome 64

Strata Oncology Enters into Agreement with Thermo Fisher Scientific 65

Thermo Fisher Scientific Partners with University of Birmingham 66

HTG Molecular Diagnostics Enters into Agreement with Thermo Fisher Scientific 67

HTG Molecular Diagnostics Enters into Co-Development Agreement with Life Technologies 68

Thermo Fisher Scientific Enters into Co-Development Agreement with Children's Hospital Los Angeles 69

Invivoscribe Enters into Co-Development Agreement with Thermo Fisher Scientific 70

Affymetrix Enters into Agreement with Reveal Biosciences 71

Thermo Fisher Scientific Enters into Agreement with Novartis and Pfizer 72

Agilent Technologies Enters into Agreement with Thermo Fisher Scientific 73

XRGenomics Enters into Research Agreement with Affymetrix 74

Affymetrix Enters into Distribution Agreement with Luminex 75

Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 76

Cytox Enters into Joint Development Partnership with Affymetrix 77

Atossa Genetics Enters into Distribution Agreement with Thermo Fisher 78

Thermo Fisher Scientific Enters into Distribution Agreement with Cynvenio Biosystems 79

Thermo Fisher Scientific Enters into Co-Development Agreement with Samsung Electronics 80

Ingen Expands Distribution Agreement with One Lambda 81

Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 82

Lucigen Enters into Agreement with Thermo Fisher Scientific 83

Nuclea Biotech Enters into Co-Development Agreement with Thermo Fisher Scientific 84

Thermo Fisher Scientific Enters into Co-Development Agreement with Agricultural Research Service and Pennsylvania State University 85

Affymetrix Enters Into Integration Agreement With CollabRx 86

Copan Diagnostics Enters Into Distribution Agreement With Thermo Fisher For WASP 87

OraSure Technologies Enters Into Co-Development Agreement With Thermo Fisher 88

Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit 89

Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 90

Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 91

Life Technologies Enters Into Agreement With RainTree For Molecular Tumor Testing 92

Rheonix Enters Into Co-Development Agreement With Life Technologies For Molecular Testing Platform 93

Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics 94

Thermo Fisher Scientific And NLIPCC Enter Into R&D Agreement For Personalized Cancer Treatment 95

Atossa Genetics Enters Into Distribution Agreement With Fisher Healthcare For Breast Health Devices 96

Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 97

Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools 98

Life Tech Enters Into Distribution Agreement With LGC Forensics For ParaDNA 99

Thermo Fisher Scientific Enters Into Research Agreement With University of Birmingham 100

Life Technologies And IMEGEN Enter Into Agreement To Develop DNA Test 101

Response Biomedical Enters Into Distribution Agreement With Fisher HealthCare 102

BioDesign Institute Enters Into Co-Development Agreement With Life Technologies 103

Affymetrix Enters Into Agreement With Hamilton Robotics To Develop Cytogenetics Assay 104

Boston Children's Hospital Enters Into Joint Venture With Life Technologies To Form Claritas Genomics 105

Biocept Enters into Partnership with Life Technologies 106

Thermo Fisher Enters Into Co-Development Agreement With Immundiagnostik 107

Ingenuity Systems Enters Into Co-Development Agreement With Life Technologies For Diagnostic Solutions 108

CollabRx Enters Into Co-Development Agreement With Life Technologies 109

Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 110

Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 111

Life Technologies Enters Into Agreement With Bristol-Myers Squibb For Companion Diagnostics Development 112

Affymetrix Enters Into Co-Development Agreement With Pathgen Dx 113

Life Technologies and Southern African Treatment and Resistance Network Partner In Sequencing-Based Surveillance of Drug Resistance 114

Gen-Probe Enters Into Co-Marketing Agreement With Life Technologies 115

One Lambda Enters Into Co-Marketing Agreement With CellTrend 116

Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests 117

Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 118

Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 119

Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology 120

Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products 121

Iris International Enters Into Distribution Agreement With Fisher HealthCare 122

IRIS Sample Processing Enters Into Distribution Agreement With Fisher HealthCare 123

Thermo Fisher Scientific Enters Into Distribution Agreement With BellBrook Labs 124

Aushon BiosyStems Enters Into Distribution Agreement With Fisher Scientific 125

Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis 126

Life Technologies Enters Into Joint Venture Agreement With DaAn Gene 127

Eppendorf Enters into Licensing Agreement with Life Tech and Alpha Labs 128

Life Technologies Enters Into Licensing Agreement With Novartis 129

Thermo Fisher Scientific Enter Into Licensing Agreement With Protein Metric For Proteomics Software 130

Thermo Fisher Scientific Prices Public Offering of Shares for USD1.5 Billion 131

Affymetrix to Raise USD50 Million in Private Placement of Shares 133

Thermo Fisher Scientific Announces Private Placement Of Common Stock For USD 500 Million 134

Thermo Fisher Completes Public Offering Of Shares For USD 2.53 Billion 135

Patheon Completes Rights Offering Of Shares For USD 30 Million 137

Affymetrix Files Registration Statement For Public Offering Of Securities For USD 200 Million 138

Thermo Fisher Scientific Prices Public Offering of Notes Due 2020 for USD694 Million 139

Thermo Fisher Scientific Raises USD750 Million in Public Offering of 3.2% Notes Due 2027 140

Thermo Fisher Scientific Raises USD750 Million in Public Offering of 4.1% Notes Due 2047 142

Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.4% Notes Due 2026 144

Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 2.875% Notes Due 2037 146

Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.95% Notes Due 2029 148

Thermo Fisher Scientific Raises USD573.3 Million in Public Offering of Floating Rate Notes Due 2019 150

Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million 152

Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes 154

Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028 156

Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028 158

Thermo Fisher Scientific Raises USD1 Billion in Public Offering of 3% Notes Due 2023 160

Thermo Fisher Scientific Raises USD350 Million in Public Offering of 3.65% Notes Due 2025 161

Thermo Fisher Scientific Raises USD450 Million in Public Offering of 2.150% Notes Due 2018 162

Thermo Fisher Scientific Raises USD457 Million in Public Offering of 1.5% Notes Due 2020 163

Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022 165

Thermo Fisher Scientific Raises USD801 Million in Public Offering of 2% Notes Due 2025 167

Thermo Fisher Scientific Raises USD800 Million in Public Offering of 3.3% Notes Due 2022 169

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2044 For USD 400 Million 171

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2024 For USD 1 Billion 173

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2019 For USD 900 Million 175

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2017 For USD 900 Million 177

Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2018 For USD 500 Million 179

Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2023 For USD 800 Million 181

Affymetrix Completes Public Offering Of Notes Due 2019 For USD 105 Million 183

Thermo Fisher Scientific Acquires IntegenX 185

One Lambda Acquires Linkage Biosciences 186

Thermo Fisher Scientific Acquires Finesse Solutions 187

Thermo Fisher Scientific Acquires FEI for USD4.2 Billion 188

Thermo Fisher Scientific May Acquire Illumina for USD30 Billion 190

Thermo Fisher Scientific Acquires Affymetrix for up to USD1.3 Billion 191

Thermo Fisher Scientific Acquires INEL 193

Thermo Fisher Scientific Acquires Advanced Scientifics for USD289 Million 194

FEI Company Acquires KonTEM, Developer of Innovative Phase Contrast System for TEM 195

EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For USD 4 Million 196

Thermo Fisher Scientific Completes Acquisition Of Life Technologies For USD 13.6 Billion 197

FEI Company To Acquire nanoTechnology Systems 200

Life Technologies Acquires KDR Biotech, Distributor Of Reagents 201

Thermo Fisher Scientific Acquires picoSpin, Maker Of Miniature Nuclear Magnetic Resonance Spectrometer 202

Life Technologies Acquires Advanced Microscopy, Maker Of Microscopes 203

Thermo Fisher Scientific Completes Acquisition Of One Lambda, Transplant Diagnostics Company, For USD 925 Million 204

FEI Acquires Visualization Sciences, 3D Visualization Software Company, For USD 55 Million 206

Life Technologies Acquires Pinpoint Genomics, Molecular Diagnostics Company 207

Life Technologies Acquires Navigenics 208

Affymetrix Completes Acquisition Of eBioscience For USD 315 Million 209

IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences 211

Life Technologies Acquires Immuno-Magnetic Diagnostics Company, Matrix MicroScience 212

Thermo Fisher Scientific Inc, Key Competitors 213

Thermo Fisher Scientific Inc, Key Employees 214

Thermo Fisher Scientific Inc, Subsidiaries 216

Thermo Fisher Scientific Inc, Joint Venture 220

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Thermo Fisher Scientific Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Thermo Fisher Scientific Inc (Thermo Fisher) is a provider of equipment, analytical instruments, reagents and consumables, software and services to tackle complex analytical challenges in research, diagnostics and clinical laboratories. It offers solutions for cellular analysis and biology, flow cytometry and synthetic biology. The company's product portfolio includes technologies for mass spectrometry, electron microscopy, genetic sequencing, protein and molecular biology research. The company serves pharmaceutical and biotech companies, academic and research institutions, clinical diagnostic labs, and government agencies; and environmental, industrial quality and process control sectors. It sells its products and services through direct sales force, e-commerce and third-party distributors in the Americas, Asia-Pacific and Europe. Thermo Fisher is headquartered in Waltham, Massachusetts, the US.

Thermo Fisher Scientific Inc (TMO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 9

List of Figures 12

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 13

Thermo Fisher Scientific Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 14

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 15

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 16

Thermo Fisher Scientific Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 17

Thermo Fisher Scientific Inc, Medical Equipment, Deal Details 24

Asset Purchase 24

Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from Becton, Dickinson and Company 24

Visualization Sciences Completes Acquisition Of Amira 3D Visualization And Analysis Software From Visage Imaging For USD 15 Million 25

Thermo Fisher Scientific Acquires Rights To Pre-eclampsia Biomarker From Nephromics 26

Venture Financing 27

Linkage Biosciences Raises USD 2 Million In Series C Financing 27

IntegenX Raises USD 49 Million In Venture Financing 28

Linkage Biosciences Raises USD 1.5 Million In Venture Financing 29

KonTEM Raises Funds Through Venture Financing 30

Private Equity 31

GTCR Completes Acquisition of Cole-Parmer from Thermo Fisher for USD480 Million 31

Partnerships 32

Thermo Fisher Enters into Licensing Agreement with Siemens Healthineers 32

One Lambda Enters into Licensing Agreement with Transcriptome Sciences 33

Singulex Enters into Licensing agreement with Thermo Fisher Scientific 34

Thermo Fisher Scientific Enters into Licensing Agreement with Probiogen for GlymaxX Technology 35

Affymetrix Enters into Licensing Agreement with Peptide Groove 36

diaDexus Enters Into Licensing Agreement With Thermo Fisher Scientific 37

Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 38

Thermo Fisher Scientific Extends Licensing Agreement With Roche For Procalcitonin Test 39

Medicyte Enters Into Licensing Agreement With Life Technologies For Next Generation Upcyte Cells 40

Life Technologies Enters Into Licensing And Research Agreement With Harvard For Stem Cell Assay 41

Affymetrix Enters Into Licensing Agreement With DNA Link To Develop Forensic And Other Diagnostic Tests 42

Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 43

Vela Diagnostics Enters Into Licensing Agreement With Life Technologies 44

Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology 45

Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology 46

Thermo Fisher Scientific Extends Licensing Agreement With Wako Pure Chemical Industries 47

PharmaFluidics Enters into Partnership Agreement with Thermo Fisher 48

Thermo Fisher and Evosep Enter into Partnership 49

Spectrum Pharma Enters into Agreement with Thermo Fisher Scientific 50

Thermo Fisher and Leica Microsystems Enter into Partnership 51

Ortho Clinical Diagnostics Enters into Distribution and Co-Promotion Agreement with Thermo Fisher Scientific 52

BioDiscovery Enters into Agreement with Thermo Fisher Scientific 53

Thermo Fisher Scientific Enters into Agreement with Blueprint Medicines 54

Genomics England, Inivata and Thermo Fisher Enter into Agreement 55

Seegene Enters into Agreement with Thermo Fisher Scientific 56

Thermo Fisher Scientific Enters into Agreement with Agios Pharma 57

Thermo Fisher Scientific Enters into Agreement with Institute of Medical Genetics and Pathology at University Hospital 58

Asuragen Enters into Agreement with Thermo Fisher Scientific 59

Invivoscribe Enters into Agreement with Thermo Fisher Scientific 60

Biocartis Group Enters into Distribution Agreement with Thermo Fisher Scientific 61

Thermo Fisher Scientific Enters into Agreement with Hamilton Storage Technologies 62

Thermo Fisher Scientific Enters into Co-Development Agreement with HEALTH BioMed 63

Thermo Fisher Scientific Enters into Co-Development Agreement with Cytonome 64

Strata Oncology Enters into Agreement with Thermo Fisher Scientific 65

Thermo Fisher Scientific Partners with University of Birmingham 66

HTG Molecular Diagnostics Enters into Agreement with Thermo Fisher Scientific 67

HTG Molecular Diagnostics Enters into Co-Development Agreement with Life Technologies 68

Thermo Fisher Scientific Enters into Co-Development Agreement with Children's Hospital Los Angeles 69

Invivoscribe Enters into Co-Development Agreement with Thermo Fisher Scientific 70

Affymetrix Enters into Agreement with Reveal Biosciences 71

Thermo Fisher Scientific Enters into Agreement with Novartis and Pfizer 72

Agilent Technologies Enters into Agreement with Thermo Fisher Scientific 73

XRGenomics Enters into Research Agreement with Affymetrix 74

Affymetrix Enters into Distribution Agreement with Luminex 75

Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 76

Cytox Enters into Joint Development Partnership with Affymetrix 77

Atossa Genetics Enters into Distribution Agreement with Thermo Fisher 78

Thermo Fisher Scientific Enters into Distribution Agreement with Cynvenio Biosystems 79

Thermo Fisher Scientific Enters into Co-Development Agreement with Samsung Electronics 80

Ingen Expands Distribution Agreement with One Lambda 81

Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 82

Lucigen Enters into Agreement with Thermo Fisher Scientific 83

Nuclea Biotech Enters into Co-Development Agreement with Thermo Fisher Scientific 84

Thermo Fisher Scientific Enters into Co-Development Agreement with Agricultural Research Service and Pennsylvania State University 85

Affymetrix Enters Into Integration Agreement With CollabRx 86

Copan Diagnostics Enters Into Distribution Agreement With Thermo Fisher For WASP 87

OraSure Technologies Enters Into Co-Development Agreement With Thermo Fisher 88

Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit 89

Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 90

Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 91

Life Technologies Enters Into Agreement With RainTree For Molecular Tumor Testing 92

Rheonix Enters Into Co-Development Agreement With Life Technologies For Molecular Testing Platform 93

Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics 94

Thermo Fisher Scientific And NLIPCC Enter Into R&D Agreement For Personalized Cancer Treatment 95

Atossa Genetics Enters Into Distribution Agreement With Fisher Healthcare For Breast Health Devices 96

Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 97

Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools 98

Life Tech Enters Into Distribution Agreement With LGC Forensics For ParaDNA 99

Thermo Fisher Scientific Enters Into Research Agreement With University of Birmingham 100

Life Technologies And IMEGEN Enter Into Agreement To Develop DNA Test 101

Response Biomedical Enters Into Distribution Agreement With Fisher HealthCare 102

BioDesign Institute Enters Into Co-Development Agreement With Life Technologies 103

Affymetrix Enters Into Agreement With Hamilton Robotics To Develop Cytogenetics Assay 104

Boston Children's Hospital Enters Into Joint Venture With Life Technologies To Form Claritas Genomics 105

Biocept Enters into Partnership with Life Technologies 106

Thermo Fisher Enters Into Co-Development Agreement With Immundiagnostik 107

Ingenuity Systems Enters Into Co-Development Agreement With Life Technologies For Diagnostic Solutions 108

CollabRx Enters Into Co-Development Agreement With Life Technologies 109

Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 110

Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 111

Life Technologies Enters Into Agreement With Bristol-Myers Squibb For Companion Diagnostics Development 112

Affymetrix Enters Into Co-Development Agreement With Pathgen Dx 113

Life Technologies and Southern African Treatment and Resistance Network Partner In Sequencing-Based Surveillance of Drug Resistance 114

Gen-Probe Enters Into Co-Marketing Agreement With Life Technologies 115

One Lambda Enters Into Co-Marketing Agreement With CellTrend 116

Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests 117

Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 118

Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 119

Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology 120

Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products 121

Iris International Enters Into Distribution Agreement With Fisher HealthCare 122

IRIS Sample Processing Enters Into Distribution Agreement With Fisher HealthCare 123

Thermo Fisher Scientific Enters Into Distribution Agreement With BellBrook Labs 124

Aushon BiosyStems Enters Into Distribution Agreement With Fisher Scientific 125

Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis 126

Life Technologies Enters Into Joint Venture Agreement With DaAn Gene 127

Eppendorf Enters into Licensing Agreement with Life Tech and Alpha Labs 128

Life Technologies Enters Into Licensing Agreement With Novartis 129

Thermo Fisher Scientific Enter Into Licensing Agreement With Protein Metric For Proteomics Software 130

Equity Offering 131

Thermo Fisher Scientific Prices Public Offering of Shares for USD1.5 Billion 131

Affymetrix to Raise USD50 Million in Private Placement of Shares 133

Thermo Fisher Scientific Announces Private Placement Of Common Stock For USD 500 Million 134

Thermo Fisher Completes Public Offering Of Shares For USD 2.53 Billion 135

Patheon Completes Rights Offering Of Shares For USD 30 Million 137

Affymetrix Files Registration Statement For Public Offering Of Securities For USD 200 Million 138

Debt Offering 139

Thermo Fisher Scientific Prices Public Offering of Notes Due 2020 for USD694 Million 139

Thermo Fisher Scientific Raises USD750 Million in Public Offering of 3.2% Notes Due 2027 140

Thermo Fisher Scientific Raises USD750 Million in Public Offering of 4.1% Notes Due 2047 142

Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.4% Notes Due 2026 144

Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 2.875% Notes Due 2037 146

Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.95% Notes Due 2029 148

Thermo Fisher Scientific Raises USD573.3 Million in Public Offering of Floating Rate Notes Due 2019 150

Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million 152

Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes 154

Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028 156

Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028 158

Thermo Fisher Scientific Raises USD1 Billion in Public Offering of 3% Notes Due 2023 160

Thermo Fisher Scientific Raises USD350 Million in Public Offering of 3.65% Notes Due 2025 161

Thermo Fisher Scientific Raises USD450 Million in Public Offering of 2.150% Notes Due 2018 162

Thermo Fisher Scientific Raises USD457 Million in Public Offering of 1.5% Notes Due 2020 163

Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022 165

Thermo Fisher Scientific Raises USD801 Million in Public Offering of 2% Notes Due 2025 167

Thermo Fisher Scientific Raises USD800 Million in Public Offering of 3.3% Notes Due 2022 169

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2044 For USD 400 Million 171

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2024 For USD 1 Billion 173

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2019 For USD 900 Million 175

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2017 For USD 900 Million 177

Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2018 For USD 500 Million 179

Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2023 For USD 800 Million 181

Affymetrix Completes Public Offering Of Notes Due 2019 For USD 105 Million 183

Acquisition 185

Thermo Fisher Scientific Acquires IntegenX 185

One Lambda Acquires Linkage Biosciences 186

Thermo Fisher Scientific Acquires Finesse Solutions 187

Thermo Fisher Scientific Acquires FEI for USD4.2 Billion 188

Thermo Fisher Scientific May Acquire Illumina for USD30 Billion 190

Thermo Fisher Scientific Acquires Affymetrix for up to USD1.3 Billion 191

Thermo Fisher Scientific Acquires INEL 193

Thermo Fisher Scientific Acquires Advanced Scientifics for USD289 Million 194

FEI Company Acquires KonTEM, Developer of Innovative Phase Contrast System for TEM 195

EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For USD 4 Million 196

Thermo Fisher Scientific Completes Acquisition Of Life Technologies For USD 13.6 Billion 197

FEI Company To Acquire nanoTechnology Systems 200

Life Technologies Acquires KDR Biotech, Distributor Of Reagents 201

Thermo Fisher Scientific Acquires picoSpin, Maker Of Miniature Nuclear Magnetic Resonance Spectrometer 202

Life Technologies Acquires Advanced Microscopy, Maker Of Microscopes 203

Thermo Fisher Scientific Completes Acquisition Of One Lambda, Transplant Diagnostics Company, For USD 925 Million 204

FEI Acquires Visualization Sciences, 3D Visualization Software Company, For USD 55 Million 206

Life Technologies Acquires Pinpoint Genomics, Molecular Diagnostics Company 207

Life Technologies Acquires Navigenics 208

Affymetrix Completes Acquisition Of eBioscience For USD 315 Million 209

IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences 211

Life Technologies Acquires Immuno-Magnetic Diagnostics Company, Matrix MicroScience 212

Thermo Fisher Scientific Inc - Key Competitors 213

Thermo Fisher Scientific Inc - Key Employees 214

Thermo Fisher Scientific Inc - Locations And Subsidiaries 216

Head Office 216

Other Locations & Subsidiaries 216

Joint Venture 220

Recent Developments 221

Strategy And Business Planning 221

Oct 02, 2018: Seoul St Mary s Hospital and Singapore General Hospital join Thermo Fisher Scientific s Next-Generation Sequencing Center of Excellence Program 221

Sep 20, 2018: Thermo Fisher scientific to launch global customer solution centers 222

Jun 04, 2018: Thermo Fisher Scientific Opens U.S. Precision Medicine Science Center 223

Mar 16, 2018: Thermo Fisher Scientific Announces Plans To Build State-Of-The-Art Pharma Services Facility In Rheinfelden 224

Dec 29, 2017: Thermo Fisher Scientific Completes Acquisition of Phenom-World 225

Financial Announcements 226

Jul 25, 2018: Thermo Fisher Scientific reports second quarter 2018 results 226

Apr 25, 2018: Thermo Fisher Scientific Reports First Quarter 2018 Results 228

Jan 31, 2018: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2017 Results 230

Oct 25, 2017: Thermo Fisher Scientific Reports Third Quarter 2017 Results 232

Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 235

Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific 237

Apr 26, 2017: Thermo Fisher Scientific Reports First Quarter 2017 Results 238

Jan 31, 2017: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results 240

Corporate Communications 242

Jul 09, 2018: Thermo Fisher Offers to Donate DNA Analyzers to Support US-Mexico Border Family Reunions 242

Jun 24, 2018: Thermo Fisher Scientific Donates Rapid DNA Analysis Technology to Help Reunite Families Recently Separated at Border 243

Jan 22, 2018: Secured loan facility agreement with Thermo Fisher 244

Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific 245

Mar 01, 2017: Thermo Fisher Scientific Elects New Director to Board 246

Legal and Regulatory 247

Mar 27, 2018: New Salmonella Multiplex PCR Solution for Simultaneous Detection of Three Salmonella Targets in One Rapid Test is Now Certified by AFNOR 247

Jan 23, 2017: ISO 17025 Accreditation for Microbiology Manufacturing Site Offers Increased Confidence to Microbiology Testing Laboratories 248

Product News 249

Sep 24, 2018: New Single Quadrupole Mass Spectrometry Technology Designed for Chromatographers Performing LC-MS Routine Analysis 249

Aug 06, 2018: Thermo Fisher Scientific Showcases New Electron Microscopy and Microanalysis Solutions at M&M 2018 250

Jul 31, 2018: New triple quadrupole mass spectrometer offers robust and fast analysis with LC-MS/MS for clinical research laboratories 252

Jul 02, 2018: Latin American Structural Biologists Gain Access to Cryo-EM Capabilities 253

Jun 28, 2018: Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Assay Portfolio 254

Jun 25, 2018: New Twin-screw Granulator Helps Maximize Throughput in Continuous Drug Manufacturing 255

Jun 18, 2018: Thermo Fisher Scientific Launches Ion AmpliSeq HD Technology 256

Jun 04, 2018: New Ultra-High Mass Range Mass Spectrometer Provides Solution for Analysis of Proteins and Protein Complexes 257

Jun 04, 2018: Thermo Fisher Scientific showcases newest products at ASMS 2018 258

Apr 26, 2018: Thermo Scientific Explorer 4 Additive Scanning Electron Microscope Delivers First Dedicated Solution for 3D Printing Process Control 260

Apr 16, 2018: Thermo Fisher Scientific Launches Oncomine Childhood Cancer Research Assay and Establishes International Childhood Oncology Network 261

Apr 12, 2018: Thermo Fisher Scientific to Showcase Clinical Research Advances in Immuno-Oncology at AACR 262

Apr 10, 2018: Thermo Fisher launches five new products at Analytica 2018 263

Apr 10, 2018: Thermo Fisher Scientific Highlights Digital Science Innovations at Analytica 2018 264

Feb 27, 2018: Thermo Fisher Scientific Innovations Offer Greater Connectivity and Ease of Use 266

Feb 05, 2018: Thermo Fisher Scientific Launches Axiom Microbiome Array for Research 267

Jan 08, 2018: Thermo Fisher Scientific Expands Oncomine Portfolio for Liquid Biopsy and Immuno-oncology Clinical Research 268

Jan 08, 2018: Thermo Fisher Scientific Introduces Ion GeneStudio S5 Series, A Line of Highly Versatile Next Generation Sequencers 270

Dec 07, 2017: New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes 271

Nov 27, 2017: Expanded Genome Editing Tool Kit Supports Every Step in Researchers' Workflow 272

Nov 04, 2017: Thermo Fisher Scientific Showcases Large-scale Precision Medicine Research Studies in Genotyping 273

Oct 17, 2017: Thermo Fisher Scientific Customers to Showcase Innovations in Precision Genomics Research for Inherited Disease and Reproductive Health at ASHG 274

Sep 26, 2017: Thermo Fisher Scientific Continues to Expand Plasmid DNA Purification Portfolio of Low-Endotoxin Plasmid DNA Isolation Kits 275

Sep 05, 2017: New Study Confirms High Technical Comparability of Different BRAHMS PCT Assays at all Clinical Cut-offs for Various Clinical Settings 276

Aug 31, 2017: Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research Across Europe 277

Aug 07, 2017: Thermo Fisher Scientific Showcases Innovations in Electron Microscopy and Spectroscopy at M&M 2017 278

Jul 31, 2017: Thermo Fisher Scientific Advances Innovation for the Clinic at AACC 2017 279

Jun 29, 2017: New FDA-Cleared Microbroth Dilution Susceptibility Testing Plate Expands Patient Treatment Options for Gram Negative Infections 280

Jun 05, 2017: Thermo Fisher Scientific and BIOCRATES Life Sciences Launch Industry's First Kit for Comprehensive Metabolome Analysis 281

Jun 02, 2017: Newly Redesigned Panels Align with Most Recent Published Evidence to Drive Cancer Research 282

May 24, 2017: New On-Demand Targeted Next-Generation Sequencing Panels for Inherited Disease Research Deliver User Customization Without High Upfront Cost 283

May 22, 2017: Thermo Fisher Scientific Introduces Latest in Capillary Electrophoresis Technology with new Applied Biosystems SeqStudio Genetic Analyzer 284

Mar 21, 2017: New Comprehensive Carrier Screening Research Assay Features Richest Pan-Ethnic Panel for Detection of Multiple Genetic Variations in Inherited Disease 285

Mar 20, 2017: Thermo Fisher Scientific Showcases Newest Bioprocessing Technologies at INTERPHEX 286

Other Significant Developments 287

Oct 02, 2018: Seoul St. Mary''s Hospital and Singapore General Hospital join Thermo Fisher Scientific''s next-generation sequencing Center of Excellence Program 287

Jul 10, 2018: Thermo Fisher Scientific to publish antibody data 288

May 18, 2018: Bard1 Enters agreement to Develop a Research-Use-Only Auto antibody Test System Using Procartaplex Technology 289

Mar 28, 2018: Biocept and Thermo Fisher Scientific Enter into Technology and Commercial Collaboration 290

Mar 21, 2018: Thermo Fisher says UK job cuts not Brexit-related 291

Feb 21, 2018: Millions of U.S. Allergy Sufferers Now Have Access to Advanced Diagnostic Tests 292

Feb 13, 2018: OpGen Strengthens Supplier Relationship to Use Industry-Leading Real-Time PCR Technology for New Acuitas Tests 293

Jan 31, 2018: Thermo Fisher Scientific Uses Tax Reform Benefit to Make Additional Investments in Colleagues, Customers and Communities 294

Jan 08, 2018: Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology 295

Sep 07, 2017: Institute of Pathology Heidelberg Joins Thermo Fisher Scientific Center of Excellence Program to Drive Oncology Companion Diagnostic Development in Europe 296

Jun 12, 2017: Allergen Sensitization Testing Breakthrough Marks 50th Anniversary 297

May 04, 2017: New Licensing Program Facilitates Adoption of Tandem Mass Tag Technology 298

Appendix 299

Methodology 299

About GlobalData 299

Contact Us 299

Disclaimer 299


List Of Figure

List of Figures

Thermo Fisher Scientific Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 13

Thermo Fisher Scientific Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 14

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 15

Thermo Fisher Scientific Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 16


List Of Table

List of Tables

Thermo Fisher Scientific Inc, Medical Equipment, Key Facts, 2017 2

Thermo Fisher Scientific Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 13

Thermo Fisher Scientific Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 14

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 15

Thermo Fisher Scientific Inc, Deals By Market, 2012 to YTD 2018 16

Thermo Fisher Scientific Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 17

Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from Becton, Dickinson and Company 24

Visualization Sciences Completes Acquisition Of Amira 3D Visualization And Analysis Software From Visage Imaging For USD 15 Million 25

Thermo Fisher Scientific Acquires Rights To Pre-eclampsia Biomarker From Nephromics 26

Linkage Biosciences Raises USD 2 Million In Series C Financing 27

IntegenX Raises USD 49 Million In Venture Financing 28

Linkage Biosciences Raises USD 1.5 Million In Venture Financing 29

KonTEM Raises Funds Through Venture Financing 30

GTCR Completes Acquisition of Cole-Parmer from Thermo Fisher for USD480 Million 31

Thermo Fisher Enters into Licensing Agreement with Siemens Healthineers 32

One Lambda Enters into Licensing Agreement with Transcriptome Sciences 33

Singulex Enters into Licensing agreement with Thermo Fisher Scientific 34

Thermo Fisher Scientific Enters into Licensing Agreement with Probiogen for GlymaxX Technology 35

Affymetrix Enters into Licensing Agreement with Peptide Groove 36

diaDexus Enters Into Licensing Agreement With Thermo Fisher Scientific 37

Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 38

Thermo Fisher Scientific Extends Licensing Agreement With Roche For Procalcitonin Test 39

Medicyte Enters Into Licensing Agreement With Life Technologies For Next Generation Upcyte Cells 40

Life Technologies Enters Into Licensing And Research Agreement With Harvard For Stem Cell Assay 41

Affymetrix Enters Into Licensing Agreement With DNA Link To Develop Forensic And Other Diagnostic Tests 42

Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 43

Vela Diagnostics Enters Into Licensing Agreement With Life Technologies 44

Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology 45

Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology 46

Thermo Fisher Scientific Extends Licensing Agreement With Wako Pure Chemical Industries 47

PharmaFluidics Enters into Partnership Agreement with Thermo Fisher 48

Thermo Fisher and Evosep Enter into Partnership 49

Spectrum Pharma Enters into Agreement with Thermo Fisher Scientific 50

Thermo Fisher and Leica Microsystems Enter into Partnership 51

Ortho Clinical Diagnostics Enters into Distribution and Co-Promotion Agreement with Thermo Fisher Scientific 52

BioDiscovery Enters into Agreement with Thermo Fisher Scientific 53

Thermo Fisher Scientific Enters into Agreement with Blueprint Medicines 54

Genomics England, Inivata and Thermo Fisher Enter into Agreement 55

Seegene Enters into Agreement with Thermo Fisher Scientific 56

Thermo Fisher Scientific Enters into Agreement with Agios Pharma 57

Thermo Fisher Scientific Enters into Agreement with Institute of Medical Genetics and Pathology at University Hospital 58

Asuragen Enters into Agreement with Thermo Fisher Scientific 59

Invivoscribe Enters into Agreement with Thermo Fisher Scientific 60

Biocartis Group Enters into Distribution Agreement with Thermo Fisher Scientific 61

Thermo Fisher Scientific Enters into Agreement with Hamilton Storage Technologies 62

Thermo Fisher Scientific Enters into Co-Development Agreement with HEALTH BioMed 63

Thermo Fisher Scientific Enters into Co-Development Agreement with Cytonome 64

Strata Oncology Enters into Agreement with Thermo Fisher Scientific 65

Thermo Fisher Scientific Partners with University of Birmingham 66

HTG Molecular Diagnostics Enters into Agreement with Thermo Fisher Scientific 67

HTG Molecular Diagnostics Enters into Co-Development Agreement with Life Technologies 68

Thermo Fisher Scientific Enters into Co-Development Agreement with Children's Hospital Los Angeles 69

Invivoscribe Enters into Co-Development Agreement with Thermo Fisher Scientific 70

Affymetrix Enters into Agreement with Reveal Biosciences 71

Thermo Fisher Scientific Enters into Agreement with Novartis and Pfizer 72

Agilent Technologies Enters into Agreement with Thermo Fisher Scientific 73

XRGenomics Enters into Research Agreement with Affymetrix 74

Affymetrix Enters into Distribution Agreement with Luminex 75

Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 76

Cytox Enters into Joint Development Partnership with Affymetrix 77

Atossa Genetics Enters into Distribution Agreement with Thermo Fisher 78

Thermo Fisher Scientific Enters into Distribution Agreement with Cynvenio Biosystems 79

Thermo Fisher Scientific Enters into Co-Development Agreement with Samsung Electronics 80

Ingen Expands Distribution Agreement with One Lambda 81

Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 82

Lucigen Enters into Agreement with Thermo Fisher Scientific 83

Nuclea Biotech Enters into Co-Development Agreement with Thermo Fisher Scientific 84

Thermo Fisher Scientific Enters into Co-Development Agreement with Agricultural Research Service and Pennsylvania State University 85

Affymetrix Enters Into Integration Agreement With CollabRx 86

Copan Diagnostics Enters Into Distribution Agreement With Thermo Fisher For WASP 87

OraSure Technologies Enters Into Co-Development Agreement With Thermo Fisher 88

Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit 89

Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 90

Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 91

Life Technologies Enters Into Agreement With RainTree For Molecular Tumor Testing 92

Rheonix Enters Into Co-Development Agreement With Life Technologies For Molecular Testing Platform 93

Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics 94

Thermo Fisher Scientific And NLIPCC Enter Into R&D Agreement For Personalized Cancer Treatment 95

Atossa Genetics Enters Into Distribution Agreement With Fisher Healthcare For Breast Health Devices 96

Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 97

Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools 98

Life Tech Enters Into Distribution Agreement With LGC Forensics For ParaDNA 99

Thermo Fisher Scientific Enters Into Research Agreement With University of Birmingham 100

Life Technologies And IMEGEN Enter Into Agreement To Develop DNA Test 101

Response Biomedical Enters Into Distribution Agreement With Fisher HealthCare 102

BioDesign Institute Enters Into Co-Development Agreement With Life Technologies 103

Affymetrix Enters Into Agreement With Hamilton Robotics To Develop Cytogenetics Assay 104

Boston Children's Hospital Enters Into Joint Venture With Life Technologies To Form Claritas Genomics 105

Biocept Enters into Partnership with Life Technologies 106

Thermo Fisher Enters Into Co-Development Agreement With Immundiagnostik 107

Ingenuity Systems Enters Into Co-Development Agreement With Life Technologies For Diagnostic Solutions 108

CollabRx Enters Into Co-Development Agreement With Life Technologies 109

Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 110

Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 111

Life Technologies Enters Into Agreement With Bristol-Myers Squibb For Companion Diagnostics Development 112

Affymetrix Enters Into Co-Development Agreement With Pathgen Dx 113

Life Technologies and Southern African Treatment and Resistance Network Partner In Sequencing-Based Surveillance of Drug Resistance 114

Gen-Probe Enters Into Co-Marketing Agreement With Life Technologies 115

One Lambda Enters Into Co-Marketing Agreement With CellTrend 116

Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests 117

Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 118

Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 119

Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology 120

Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products 121

Iris International Enters Into Distribution Agreement With Fisher HealthCare 122

IRIS Sample Processing Enters Into Distribution Agreement With Fisher HealthCare 123

Thermo Fisher Scientific Enters Into Distribution Agreement With BellBrook Labs 124

Aushon BiosyStems Enters Into Distribution Agreement With Fisher Scientific 125

Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis 126

Life Technologies Enters Into Joint Venture Agreement With DaAn Gene 127

Eppendorf Enters into Licensing Agreement with Life Tech and Alpha Labs 128

Life Technologies Enters Into Licensing Agreement With Novartis 129

Thermo Fisher Scientific Enter Into Licensing Agreement With Protein Metric For Proteomics Software 130

Thermo Fisher Scientific Prices Public Offering of Shares for USD1.5 Billion 131

Affymetrix to Raise USD50 Million in Private Placement of Shares 133

Thermo Fisher Scientific Announces Private Placement Of Common Stock For USD 500 Million 134

Thermo Fisher Completes Public Offering Of Shares For USD 2.53 Billion 135

Patheon Completes Rights Offering Of Shares For USD 30 Million 137

Affymetrix Files Registration Statement For Public Offering Of Securities For USD 200 Million 138

Thermo Fisher Scientific Prices Public Offering of Notes Due 2020 for USD694 Million 139

Thermo Fisher Scientific Raises USD750 Million in Public Offering of 3.2% Notes Due 2027 140

Thermo Fisher Scientific Raises USD750 Million in Public Offering of 4.1% Notes Due 2047 142

Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.4% Notes Due 2026 144

Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 2.875% Notes Due 2037 146

Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.95% Notes Due 2029 148

Thermo Fisher Scientific Raises USD573.3 Million in Public Offering of Floating Rate Notes Due 2019 150

Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million 152

Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes 154

Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028 156

Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028 158

Thermo Fisher Scientific Raises USD1 Billion in Public Offering of 3% Notes Due 2023 160

Thermo Fisher Scientific Raises USD350 Million in Public Offering of 3.65% Notes Due 2025 161

Thermo Fisher Scientific Raises USD450 Million in Public Offering of 2.150% Notes Due 2018 162

Thermo Fisher Scientific Raises USD457 Million in Public Offering of 1.5% Notes Due 2020 163

Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022 165

Thermo Fisher Scientific Raises USD801 Million in Public Offering of 2% Notes Due 2025 167

Thermo Fisher Scientific Raises USD800 Million in Public Offering of 3.3% Notes Due 2022 169

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2044 For USD 400 Million 171

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2024 For USD 1 Billion 173

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2019 For USD 900 Million 175

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2017 For USD 900 Million 177

Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2018 For USD 500 Million 179

Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2023 For USD 800 Million 181

Affymetrix Completes Public Offering Of Notes Due 2019 For USD 105 Million 183

Thermo Fisher Scientific Acquires IntegenX 185

One Lambda Acquires Linkage Biosciences 186

Thermo Fisher Scientific Acquires Finesse Solutions 187

Thermo Fisher Scientific Acquires FEI for USD4.2 Billion 188

Thermo Fisher Scientific May Acquire Illumina for USD30 Billion 190

Thermo Fisher Scientific Acquires Affymetrix for up to USD1.3 Billion 191

Thermo Fisher Scientific Acquires INEL 193

Thermo Fisher Scientific Acquires Advanced Scientifics for USD289 Million 194

FEI Company Acquires KonTEM, Developer of Innovative Phase Contrast System for TEM 195

EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For USD 4 Million 196

Thermo Fisher Scientific Completes Acquisition Of Life Technologies For USD 13.6 Billion 197

FEI Company To Acquire nanoTechnology Systems 200

Life Technologies Acquires KDR Biotech, Distributor Of Reagents 201

Thermo Fisher Scientific Acquires picoSpin, Maker Of Miniature Nuclear Magnetic Resonance Spectrometer 202

Life Technologies Acquires Advanced Microscopy, Maker Of Microscopes 203

Thermo Fisher Scientific Completes Acquisition Of One Lambda, Transplant Diagnostics Company, For USD 925 Million 204

FEI Acquires Visualization Sciences, 3D Visualization Software Company, For USD 55 Million 206

Life Technologies Acquires Pinpoint Genomics, Molecular Diagnostics Company 207

Life Technologies Acquires Navigenics 208

Affymetrix Completes Acquisition Of eBioscience For USD 315 Million 209

IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences 211

Life Technologies Acquires Immuno-Magnetic Diagnostics Company, Matrix MicroScience 212

Thermo Fisher Scientific Inc, Key Competitors 213

Thermo Fisher Scientific Inc, Key Employees 214

Thermo Fisher Scientific Inc, Subsidiaries 216

Thermo Fisher Scientific Inc, Joint Venture 220

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Thermo Fisher Scientific Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.